INTEGRATED IMMUNOPHENOTYPING AND DRUG RESPONSE PROFILING REVEALS SUBTYPE-SPECIFIC SUSCEPTIBILITIES IN PEDIATRIC MDS WITH EXCESS BLASTS
Nastassja Scheidegger-Egloff(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich), Luca Vinci(University Medical Center Freiburg), Marek Ussowicz(Wroclaw Medical University), Fabio D. Steffen(University Children's Hospital Zurich), Ayami Yoshimi‐Noellke(University Medical Center Freiburg), Kaan Boztuǧ(Forschungszentrum Jülich), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Ben Haladik(Austrian Academy of Sciences), Michael Dworzak(St. Anna Children's Cancer Research Institute), Barbara De Moerloose(Ghent University Hospital), Silvia Gutnik(University Children's Hospital Zurich), C.M. Moeller(University Children's Hospital Zurich), Henrik Hasle(Aarhus University Hospital), Sheila Bohler(University Medical Center Freiburg), Charlotte M. Niemeyer(University of Freiburg), Miriam Erlacher(University Hospital Ulm), Arianna Arpagaus(University Children's Hospital Zurich), Anna Hurt(St Anna Children's Hospital), Claudia M. Koebl(St Anna Children's Hospital), Margarita Maurer Granofszky(St Anna Children's Hospital), Markus Schmugge(University Children's Hospital Zurich), Selina Schuehle(University Children's Hospital Zurich), Larissa J. Schori(University Children's Hospital Zurich)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577